You are kindly invited to the 9th IMMUNO-model webinar entitled “Turning Collaboration into Funding: MSCA Doctoral Network Success from IMMUNO-model to ACHILLES” that will be streamed live on the ZOOM platform on July 4, 2025 at 2.00 – 4.00 pm CET.
This webinar will provide a comprehensive overview of the MSCA Doctoral Network application process. Laia Lagunas will begin by outlining the key sections of the proposal, explaining the evaluation criteria, and offering practical guidance on building a strong consortium. Following this, Dr. Laura Belver will present a success story from the ACHILLES MSCA Doctoral Network, recently funded in the latest call and coordinated through the IMMUNO-model Working Group 4 on hematologic malignancies. The webinar will be moderated by Rosalinda Sorrentino, University of Salermo Italy, lMMUNO-model WG5 co-leader.
Short biographies of speakers
Laia Lagunas, EU and International Strategic Grant Specialist, Strategy and Funding Department, Centre for Genomic Regulation (CRG), Barcelona, Spain
Laia Lagunas is an EU and International Strategic Grants Specialist at the Strategy and Funding Department of the Centre for Genomic Regulation (CRG). She holds degrees in Public Administration (Pompeu Fabra University) and Political Science (University of Barcelona), along with a Master’s in Internal Finance and an MBA. With over 20 years of experience in European project management, she has worked in multiple research institutions in Catalonia. Before joining CRG in 2025, she held leadership roles in project coordination and research funding. She has managed projects under FP5 to Horizon Europe, specializing in Marie Skłodowska-Curie Actions (MSCA), particularly Doctoral Networks and COFUND. She is an active member of EARMA, MCAA, CARMA and the Spanish COFUND Working Group
Laura Belver, PhD, Group Leader, Leukemia and Immuno-Oncology Group, Josep Carreras Leukemia Research Institute (IJC), Barcelona, Spain
Dr. Laura Belver earned her PhD in Molecular Biology in 2011 at the Spanish National Cancer Center (CNIO), where her research focused on the role of microRNAs in regulating B cell-driven autoimmunity. Following her doctoral studies, she joined Columbia University (USA) as a postdoctoral researcher, investigating the molecular mechanisms underlying T-cell acute lymphoblastic leukemia (T-ALL). Since 2020, Dr. Belver has led the Leukemia and Immuno-Oncology Group at the Josep Carreras Leukemia Research Institute (IJC). Her team is dedicated to uncovering the molecular drivers of leukemia and autoimmunity, as well as developing novel experimental therapies to treat these diseases. Dr. Belver currently serves as the leader of the Working Group on Hematologic Malignancies within the IMMUNO-model COST Action and is the coordinator of ACHILLES, a recently awarded MSCA Doctoral Network focused on experimental therapeutics for leukemia and lymphoma.
Check out Webinar here.